摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(E)-2-{3-(4-fluorophenyl)-4-[(hydroxyimino)methyl]-1H-pyrazol-1-yl}-1,3-benzothiazole-6-sulfonamide

中文名称
——
中文别名
——
英文名称
(E)-2-{3-(4-fluorophenyl)-4-[(hydroxyimino)methyl]-1H-pyrazol-1-yl}-1,3-benzothiazole-6-sulfonamide
英文别名
2-[3-(4-fluorophenyl)-4-[(E)-hydroxyiminomethyl]pyrazol-1-yl]-1,3-benzothiazole-6-sulfonamide
(E)-2-{3-(4-fluorophenyl)-4-[(hydroxyimino)methyl]-1H-pyrazol-1-yl}-1,3-benzothiazole-6-sulfonamide化学式
CAS
——
化学式
C17H12FN5O3S2
mdl
——
分子量
417.444
InChiKey
AXXWWYHZBZVCMD-DNTJNYDQSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    28
  • 可旋转键数:
    4
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    160
  • 氢给体数:
    2
  • 氢受体数:
    9

反应信息

  • 作为产物:
    描述:
    2-hydrazinobenzothiazole-6-sulfonic acid amide盐酸乙醇盐酸羟胺溶剂黄146 作用下, 以 四氢呋喃乙醇N,N-二甲基甲酰胺 为溶剂, 生成 (Z)-2-{3-(4-fluorophenyl)-4-[(hydroxyimino)methyl]-1H-pyrazol-1-yl}-1,3-benzothiazole-6-sulfonamide 、 (E)-2-{3-(4-fluorophenyl)-4-[(hydroxyimino)methyl]-1H-pyrazol-1-yl}-1,3-benzothiazole-6-sulfonamide
    参考文献:
    名称:
    4-Functionalized 1,3-diarylpyrazoles bearing 6-aminosulfonylbenzothiazole moiety as potent inhibitors of carbonic anhydrase isoforms hCA I, II, IX and XII
    摘要:
    A series of 24 novel heterocyclic compounds-functionalized at position 4 with aldehyde (5a-5f), carboxylic acid (6a-6f), nitrile (7a-7f) and oxime (8a-8f) functional groups-bearing 6-aminosulfonybenzothiazole moiety at position 1 of pyrazole has been synthesized and investigated for the inhibition of four isoforms of the alpha-class carbonic anhydrases (CAs, EC 4.2.1.1), comprising hCAs I and II (cytosolic, ubiquitous isozymes) and hCAs IX and XII (transmembrane, tumor associated isozymes). Against the human isozyme hCA I, compounds 6a-6f showed medium-weak inhibitory potential with Ki values in the range of 157-690 nM with 6a showing better potential than the standard drug acetazolamide (AZA). Against hCA II, all the compounds showed excellent to moderate inhibition with Ki values of compounds 5a, 5d, 5f, 6a-6f, 8d and 8f lower than 12 nM (Ki of AZA). Against hCA IX, all the compounds showed moderate inhibition with the exception of 6e which showed nearly 9 fold a better profile compared to AZA, whereas against hCA XII, four compounds 6e, 7a, 7b and 7d showed Ki in the same order as that of AZA. Carboxylic acid 6e was found to be an excellent inhibitor of both hCA IX and XII, with Ki values of 2.8 nM and 5.5 nM, respectively. (C) 2014 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2014.10.018
点击查看最新优质反应信息